These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4013413)

  • 41. [Local and general immune responses in rabbits after intratracheal administration of influenza virus (author's transl)].
    Riottot MM; Thibon M; Pillot J
    Ann Microbiol (Paris); 1977; 128A(4):459-75. PubMed ID: 911110
    [No Abstract]   [Full Text] [Related]  

  • 42. [Dynamics of the specific antibodies in persons with unaltered palatine tonsils, in chronic tonsillitis and in persons with the tonsils removed immunized with a live influenza vaccine].
    Gorbachevskiĭ VN
    Zh Ushn Nos Gorl Bolezn; 1978; (1):67-74. PubMed ID: 636625
    [No Abstract]   [Full Text] [Related]  

  • 43. [Safety of viral vaccines (a review)].
    Peradze TV; Fridman EA
    Tr Inst Im Pastera; 1979; 52():9-18. PubMed ID: 550552
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of HLA in immune response to influenza-A immunization.
    Cunningham-Rundles S; Brown A; Gross D; Braun D; Hansen JA; Good RA; Armstrong D; Dupont B
    Transplant Proc; 1979 Dec; 11(4):1849-52. PubMed ID: 394432
    [No Abstract]   [Full Text] [Related]  

  • 45. [Secretory immunity in persons inoculated with killed influenza vaccine purified and concentrated on silicate sorbents].
    Bichurina MA
    Tr Inst Im Pastera; 1976; 47():134-40. PubMed ID: 210539
    [No Abstract]   [Full Text] [Related]  

  • 46. Immune response to influenza vaccination.
    Künzel W; Engelmann H; D'Hondt E
    Lancet; 1994 Jan; 343(8890):173. PubMed ID: 7904017
    [No Abstract]   [Full Text] [Related]  

  • 47. Clonal antibody dominance after influenza vaccination in IgA nephropathy patients and controls.
    Radl J; Hoogeveen CM; van den Wall Bake AW; Mestecky J
    Adv Exp Med Biol; 1995; 371B():829-34. PubMed ID: 7502907
    [No Abstract]   [Full Text] [Related]  

  • 48. Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection.
    Tannock GA; Paul JA; Herd R; Barry RD; Reid AL; Hensley MJ; Gillett RS; Gillett SM; Lawrance P; Henry RL
    J Clin Microbiol; 1989 Mar; 27(3):524-8. PubMed ID: 2715324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secretory antibodies in respiratory virus infections.
    Petrescu A
    Virologie; 1984; 35(2):133-8. PubMed ID: 6330974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Virologic-immunological basis and current status of influenza vaccination in the Federal Republic of Germany].
    Kuwert EK
    Med Welt; 1977 Oct; 28(40):1599-1610. PubMed ID: 927117
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
    Potter CW; Jennings R; Nicholson K
    Med Microbiol Immunol; 1978 Nov; 166(1-4):99-108. PubMed ID: 723794
    [No Abstract]   [Full Text] [Related]  

  • 52. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1988 Feb; 259(6):798, 803-4. PubMed ID: 3336191
    [No Abstract]   [Full Text] [Related]  

  • 53. Occurrence of influenza antibodies in Addis Ababa.
    Abebe A; Gebreselassie L
    Ethiop Med J; 1986 Jul; 24(3):145-7. PubMed ID: 3720736
    [No Abstract]   [Full Text] [Related]  

  • 54. Influenza subtype-specific immunoglobulin A and G responses after booster versus one double-dose vaccination in hemodialysis patients.
    Rautenberg P; Proppe D; Schütte A; Ullmann U
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):897-900. PubMed ID: 2512137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Serological and clinical studies on an epidemic of influenza type B].
    Niwa A
    Nihon Ika Daigaku Zasshi; 1985 Apr; 52(2):123-30. PubMed ID: 3998076
    [No Abstract]   [Full Text] [Related]  

  • 56. [Secretory immunity of the nasal mucosa and its relevance to influenza].
    Meyer P; Werner E
    Z Arztl Fortbild (Jena); 1985; 79(5):195-7. PubMed ID: 2408391
    [No Abstract]   [Full Text] [Related]  

  • 57. [Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines].
    Naĭkhin AN; Rudenko LG; Arden N; Katz J; Grigor'eva EP; Rekstin AR; Desheva IuA; Cox N
    Vopr Virusol; 1998; 43(1):20-4. PubMed ID: 9559531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Seroepidemiological studies on an epidemic of influenza--an epidemic of influenza type B as examined with serological reactions as indicators].
    Satsuta K; Noriki H; Hasebe A; Nakayama M; Takeuchi Y
    Kansenshogaku Zasshi; 1984 May; 58(5):408-16. PubMed ID: 6434665
    [No Abstract]   [Full Text] [Related]  

  • 59. The potential advantages and requirements of live attenuated influenza virus vaccines.
    Mackenzie JS
    Aust N Z J Med; 1977 Aug; 7(4):431-7. PubMed ID: 73370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cellular and humoral immunity studies after vaccination against influenza].
    Karpovich LG; Dzagurov SG; Bukovskaia SN; Romanov VL; Kalashnikova TV
    Vopr Virusol; 1982; 27(2):162-6. PubMed ID: 7090341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.